Impact of mannose-binding lectin 2 gene polymorphisms on disease severity in noncystic fibrosis bronchiectasis in children
- PMID: 32119194
- DOI: 10.1002/ppul.24711
Impact of mannose-binding lectin 2 gene polymorphisms on disease severity in noncystic fibrosis bronchiectasis in children
Abstract
Background: Mannose-binding lectin (MBL) is a complement protein involved in the innate immune system, and is associated with some chronic respiratory diseases including noncystic fibrosis (non-CF) bronchiectasis in adults. The aim of this study was to investigate the frequency of MBL2 gene polymorphisms in children with non-CF bronchiectasis, and the effect of MBL deficiency on disease severity.
Methods: Fifty children with non-CF bronchiectasis (bronchiectasis group) and 50 healthy controls (control group) were included. The demographic findings, number of acute pulmonary exacerbations in the previous year, airway cultures, pulmonary function tests, and radiologic scores of the bronchiectasis group were recorded. DNA extraction was performed in both groups and MBL2 gene polymorphisms in codons 52, 54, 57 in exon 1 and H/L, Y/X in the promoter region were studied using real-time polymerase chain reaction. Haplotypes were made by genotypes, and MBL serum expression was classified according to the genotypes in the literature.
Results: The bronchiectasis group consisted of 23 (46%) patients with primary ciliary dyskinesia, 5 (10%) with primary immunodeficiency diseases, and 22 (44%) with idiopathic bronchiectasis. There were no statistically significant differences between the bronchiectasis and control groups in terms of allele and genotype frequencies of polymorphisms in codons 52, 54, 57 in exon 1 and promoter H/L. However, the YX heterozygote genotype was more frequent in the control group (82%) compared with the bronchiectasis group (50%) (P = .002). The frequency of patients with intermediate serum MBL expression genotype was higher in the bronchiectasis group (20%) than in the control group (0%) (P = .001). In the bronchiectasis group, there were no significant differences in growth, annual pulmonary exacerbation rates in the last year, pulmonary function tests, radiologic scores, and microbiologic findings between low, intermediate, and high-expressing genotypes.
Conclusions: In children with non-CF bronchiectasis, MBL genotype was different from healthy controls. MBL deficiency associated only with MBL genotype was not related to disease severity in this group of patients.
Keywords: children; gene polymorphism; mannose-binding lectin; noncystic fibrosis bronchiectasis.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study.Lancet Respir Med. 2013 May;1(3):224-32. doi: 10.1016/S2213-2600(13)70001-8. Epub 2013 Jan 28. Lancet Respir Med. 2013. PMID: 24429128
-
The impact of mannose-binding lectin polymorphisms on lung function in primary ciliary dyskinesia.Pediatr Pulmonol. 2019 Aug;54(8):1182-1189. doi: 10.1002/ppul.24346. Epub 2019 Apr 22. Pediatr Pulmonol. 2019. PMID: 31012247
-
Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children.Respirology. 2015 Aug;20(6):982-6. doi: 10.1111/resp.12547. Epub 2015 May 4. Respirology. 2015. PMID: 25939617
-
Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis.Glycobiology. 2011 Mar;21(3):271-82. doi: 10.1093/glycob/cwq161. Epub 2010 Nov 2. Glycobiology. 2011. PMID: 21045008 Review.
-
Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis.Clin Exp Immunol. 2010 Oct;162(1):84-90. doi: 10.1111/j.1365-2249.2010.04221.x. Epub 2010 Aug 19. Clin Exp Immunol. 2010. PMID: 20636396 Free PMC article. Review.
Cited by
-
Respiratory Outcomes at 5-Year Follow-Up in Children with Mannose-Binding Lectin Deficiency: A Retrospective Cohort Study.Thorac Res Pract. 2023 Mar;24(2):85-90. doi: 10.5152/ThoracResPract.2023.22121. Thorac Res Pract. 2023. PMID: 37503644 Free PMC article.
-
The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System.Front Immunol. 2020 Oct 21;11:585243. doi: 10.3389/fimmu.2020.585243. eCollection 2020. Front Immunol. 2020. PMID: 33193407 Free PMC article. Review.
References
REFERENCES
-
- Goyal V, Grimwood K, Marchant J, Masters IB, Chang AB. Pediatric bronchiectasis: no longer an orphan disease. Pediatr Pulmonol. 2016;51:450-469.
-
- Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet. 2018;392:866-879.
-
- Chang AB, Bilton D. Exacerbations in cystic fibrosis: 4--non-cystic fibrosis bronchiectasis. Thorax. 2008;63:269-276.
-
- Satırer O, Mete Yesil A, Emiralioglu N, et al. A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: a tertiary care experience. Respir Med. 2018;137:35-39.
-
- Heitzeneder S, Seidel M, Förster-Waldl E, Heitger A. Mannan-binding lectin deficiency-good news, bad news, doesn't matter? Clin Immunol. 2012;143:22-38.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous